References
- Canadian Cancer Society. A game changer. Believe 2013; 2013 Spring/Summer [ accessed 2019 Jan 7]. http://www.cancer.ca/~/media/cancer.ca/AB/about%20us/BelieveMagazine_2013_Spring_AB.pdf?la=en.
- World Health Organization. Human papillomavirus vaccines: WHO position paper, May 2017; 2017 May 12 [ accessed 2019 Jan 7]. http://apps.who.int/iris/bitstream/handle/10665/255353/WER9219.pdf?sequence=1.
- Bruni L, Diaz M, Barrionuevo-Rosas L, Herrero R, Bray F, Bosch FX, de Sanjosé S, Castellsagué X. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Global Health. 2016;4(7):e453–e463. doi:10.1016/s2214-109x(16)30099-7.
- World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2018 global summary; 2018 Sep 21 [ accessed 2019 Jan 7]. http://apps.who.int/immunization_monitoring/globalsummary/schedules.
- Government of Canada. Canada’s provincial and territorial routine (and catch-up) vaccination routine schedule programs for infants and children; 2018 Aug [ accessed 2019 Jan 7]. https://www.canada.ca/en/public-health/services/provincial-territorial-immunization-information/provincial-territorial-routine-vaccination-programs-infants-children.html.
- Government of Newfoundland and Labrador Department of Health and Community Services. Communicable disease report: quarterly report 2015–2016; 2015 Dec [ accessed 2019 Jan 7]. http://www.health.gov.nl.ca/health/publichealth/cdc/pdf/CDR_Dec_2015_Vol_32.pdf.
- Government of Prince Edward Island. Health for all islanders: promote, prevent, protect; PEI chief public health officer’s report 2016: health PEI; 2016 [ accessed 2019 Jan 7]. https://www.princeedwardisland.ca/sites/default/files/publications/cphorpt16_linkd.pdf.
- Government of Nova Scotia. School-based immunization coverage in Nova Scotia: 2016-2017; 2018 Aug 13 [ accessed 2019 Jan 7]. https://novascotia.ca/DHW/POpulationhealth/documents/School-Based-Immunization-Coverage-Nova-Scotia-2016-2017.pdf.
- Paul Cullen. The HPV propaganda battle: the other side finally fights back. The Irish Times; 2017 Sep 16 [ accessed 2019 Jan 7]. https://www.irishtimes.com/life-and-style/health-family/the-hpv-propaganda-battle-the-other-side-finally-fights-back-1.3221166.
- Health Protection Surveillance Centre. HPV vaccine uptake in Ireland: 2016/2017; 2018 Sep 1 [ accessed 2019 Jan 7]. https://www.hpsc.ie/a-z/vaccinepreventable/vaccination/immunisationuptakestatistics/hpvimmunisationuptakestatistics/HPV%20Uptake%20Academic%20Year%202016%202017%20v1.1%2009012018.pdf.
- MacDonald NE, Sage Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–64. doi:10.1016/j.vaccine.2015.04.036.
- Weinstein ND, Sandman PM, Blalock SJ. The precaution adoption process model. In: Glanz K, Rimer BK, Viswanath K, editors. Health behavior and health education: theory, research, and practice. 4th ed. San Francisco (CA): Jossey-Bass; 2008. p. 123–48.
- Perez S, Tatar O, Gilca V, Shapiro GK, Ogilvie G, Guichon J, Naz A, Rosberger Z. Untangling the psychosocial predictors of HPV vaccination decision-making among parents of boys. Vaccine. 2017;35(36):4713–21. doi:10.1016/j.vaccine.2017.07.043.
- Shapiro GK, Tatar O, Amsel R, Prue G, Zimet GD, Knauper B, Rosberger Z. Using an integrated conceptual framework to investigate parents’ HPV vaccine decision for their daughters and sons. Prev Med. 2018;116:203–10. doi:10.1016/j.ypmed.2018.09.017.
- Perez S, Tatar O, Shapiro GK, Dube E, Ogilvie G, Guichon J, Gilca V, Rosberger Z. Psychosocial determinants of parental human papillomavirus (HPV) vaccine decision-making for sons: methodological challenges and initial results of a pan-Canadian longitudinal study. BMC Public Health. 2016;16(1):1223. doi:10.1186/s12889-016-3828-9.
- Newman PA, Logie CH, Lacombe-Duncan A, Baiden P, Tepjan S, Rubincam C, Doukas N, Asey F. Parents’ uptake of human papillomavirus vaccines for their children: a systematic review and meta-analysis of observational studies. BMJ Open. 2018;8(4):e019206. doi:10.1136/bmjopen-2017-019206.
- Tulsieram KL, Arocha JF, Lee J. Readability and coherence of department/ministry of health HPV information. J Cancer Educ. 2018;33(1):147–53. doi:10.1007/s13187-016-1082-6.
- Shapiro GK, Perez S, Naz A, Tatar O, Guichon JR, Amsel R, Zimet GD, Rosberger Z. Investigating Canadian parents’ HPV vaccine knowledge, attitudes and behaviour: a study protocol for a longitudinal national online survey. BMJ Open. 2017;7(10):e017814. doi:10.1136/bmjopen-2017-017814.
- Perez S, Tatar O, Ostini R, Shapiro GK, Waller J, Zimet G, Rosberger Z. Extending and validating a human papillomavirus (HPV) knowledge measure in a national sample of Canadian parents of boys. Prev Med. 2016;91:43–49. doi:10.1016/j.ypmed.2016.07.017.
- Perez S, Shapiro GK, Tatar O, Joyal-Desmarais K, Rosberger Z. Development and validation of the human papillomavirus attitudes and beliefs scale in a National Canadian sample. Sex Transm Dis. 2016;43(10):626–32. doi:10.1097/OLQ.0000000000000506.
- Shapiro GK, Holding A, Perez S, Amsel R, Rosberger Z. Validation of the vaccine conspiracy beliefs scale. Papillomavirus Res. 2016;2:167–72. doi:10.1016/j.pvr.2016.09.001.
- Shapiro GK, Tatar O, Dube E, Amsel R, Knauper B, Naz A, Perez S, Rosberger Z. The vaccine hesitancy scale: psychometric properties and validation. Vaccine. 2018;36(5):660–67. doi:10.1016/j.vaccine.2017.12.043.
- Hair JF, Anderson RE, Tatham RL. Multivariate data analysis. New York (NY): Macmillan; 1995.
- Hosmer DW, Hosmer T, Le Cessie S, Lemeshow S. A comparison of goodness-of-fit tests for the logistic regression model. Stat Med. 1997;16:965–80.
- Fabozzi FJ, Focardi SM, Svetlozar TR. Model selection criterion: AIC and BIC—Appendix E. The basics of financial econometrics: tools, concepts, and asset management applications. Hoboken (NJ, USA): John Wiley & Sons, Inc.; 2014. p. 399–403.